Illinois Psychiatric Society 2026 Annual Meeting
Illinois Psychiatric Society 2026 Annual Meeting
Welcome & Thank You
for Joining Us!
Meeting Program
-
1:00 - 1:40 pm
Check-In and Networking with Exhibitors1:40 - 1:45 pm
Opening Remarks and Welcome
Steven Weinstein, MD; IPS President1:45 - 2:30 pm
Session 1: Washington Update: Federal Policy Shaping Psychiatric Practice
Brooke Trainum, JD;
Senior Director, Practice Policy, APA
Trip Stanford;
Director, Federal Relations, APAAbout this Session: A review of recent federal legislative and regulatory actions affecting psychiatric practice, including developments in reimbursement, behavioral health coverage, mental health parity enforcement, telehealth policy, and workforce initiatives. Discussion will also address key administrative decisions shaping the current regulatory environment, as well as potential congressional action following the midterm elections and implications for future federal health policy. The focus will be on how these changes may affect psychiatric practice operations, compliance requirements, and care delivery.
2:30 - 3:15 pm
Session 2: ELIZA for the 21st Century: Promise and Perils of AI in Psychiatric Practice
Olu Ajilore, MD, PhD;
UI Center for Depression and Resilience Professor of Psychiatry, University of Illinois College of MedicineAbout this session: This talk will present the perils and promise of AI in psychiatric practice with a discussion of whether AI represents a net benefit or net harm for mental health.
3:15 - 4:00 pm
Poster Session/Break/Networking with Exhibitors4:00 - 4:45 pm
Session 3: Integrating Neuroscience into Clinical Psychiatry
Joseph J. Cooper, MD, FANPA
Professor of Clinical Psychiatry, Vice Chair for Education, Director of Residency Training and the Director of the Behavioral Neurology & Neuropsychiatry Fellowship in the Dept. of Psychiatry at the University of Illinois at ChicagoAbout this Session: Rapid advances in 21st century neuroscience have revolutionized a scientific understanding of psychiatric disorders, yet clinical psychiatry remains stuck in habits formed in the 20th century. This session will introduce modern educational resources essential to bridging this gap — assisting clinicians in integrating neuroscience into their daily work with patients and their families.
4:45 - 5:45 pm
Session 4: The Evolving Therapeutic Role of Psychedelics in Psychiatric Conditions: Current Data, Mechanism of Action, Multi-disciplinary Model, and Role in Clinical Practice
John Zajecka, MD
Professor of Psychiatry, Rush University Medical Center, Director, Rush University Woman’s Board Depression Treatment Research Center, Co-founder and current Managing Member of Psychiatric Medicine Associates, LLCAbout this Session: Review the current data and multi-dimensional model of mechanism of action on the use of psychedelics in the management of psychiatric conditions. The potential challenges and clinical use will also be discussed as these treatments are introduced in clinical practice.
5:45 - 7:00 pm
Cocktail Hour/Networking with Exhibitors7:00 - 9:00 pm
Awards Dinner:Business Meeting with IPS President and Executive Director
Carl Bell Essay Competition Presentation
Poster Session Winners
IPS Member Awards Ceremony
-
When Expectation Becomes an Adverse Event: Nocebo-Related Emergency Visits in a Patient With Chronic Pain
Umbar Bashir - Saint James School of MedicineElectroconvulsive Therapy as Adjunctive Treatment for Organic Catatonia: A Three-Case Series
Ciara Callanan, MD – Rush University“There’s no point—I’m already dead. I don’t need medication in heaven.”: Cotard Delusion in a Patient with Overlapping Psychiatric, Neurologic, and Genetic Features
Gabriela Fernandez, MD – Southern Illinois UniversityWhen Treatment Triggers Mania: A Case Report of Cariprazine for Management of ECT-Induced Mania in an Older Adult
Anneka Johnston, MD - Rush UniversityProlonged Visual, Tactile, Phobic Hallucinations in a Preschool-Aged Child
Austin Le - UICFrom Acute Psychosis to Refractory Malignant Catatonia: Diagnostic Ambiguity and Multimodal Management in Autoimmune Encephalitis
Stephanie Moss, MD - Rosalind FranklinFasting-Induced Manic Episode in Bipolar Disorder: A Case Report and Scoping Review of the Role of Metabolic and Circadian Rhythm Dysregulation in Bipolar Disorder
Tristayn Owen, MD – Rush UniversityRecurrent Catatonia in a Young Naval Recruit: A Diagnostic and Therapeutic Challenge
Adam Ruprecht - UICUnmasking Rare SSRI Hepatotoxicity: Severe Transaminitis Triggered by Escitalopram
Shwetha Sekar – Rush UniversityComplex Trauma, Personality Features, and Violence Risk Formulation in an Older Combat Veteran: A Case Report
Jasmeen Sidhu - Rosalind FranklinPersistent Psychosis in 22q11.2 Deletion Syndrome With Marked Improvement Following Lamotrigine Discontinuation: A Case Report
Antoniya Zheleva – Rush University -
CRP and Duloxetine in Fibromyalgia Only versus Fibromyalgia and Obstructive Sleep Apnea
Laasya Gadamsetti - Loyola University Chicago StritchImplementation and Evaluation of a Novel Trauma-Informed Group Therapy Workbook for Inpatient Navy Recruits: Exploratory Pre/Post Outcome Assessment
Suhitha Irukulla - Rosalind FranklinImmediate Staff Debriefings: Improving Safety and Resilience in Inpatient Psychiatry
Shravani Javadekar, MD – Southern Illinois UniversityPediatric Catatonia: Clinical Characteristics and Associations with Trauma and Overdose
Gabrielle Maire - Loyola University Chicago StritchDo Good, Feel Good? Investigating the Link Between Helping Others and Mental Well-being
Ami Patel – Rush UniversityOpioids and Antidepressant Use in Fibromyalgia, Sleep Apnea, and Psychiatric Co-Morbidities: Effects of CPAP on REM sleep and pain
Vir Patel - Loyola University Chicago StritchAssociations of Depression, Weight, and REM Sleep Measures with Cognitive and Memory Deficits in Older Adults with Obstructive Sleep Apnea
Mariana Perepitchka - Loyola University Chicago StritchCharacterizing Trauma Knowledge, Preparedness, and Secondary Traumatic Stress Awareness Among Educators in Urban Public Schools
Feliciano Perez, MD – Rush UniversityLong-Acting Injectable Antipsychotics in Children and Adolescents: A Scoping Review of Clinical Use, Outcomes, and Safety
Celeena Remmers - University of Illinois COM-RockfordA Systems-Level Approach to Pediatric Behavioral Health Access and Clinician Well-Being: Evaluating the Impact of Care Navigation
Naomi Sequeira, MD - Rush UniversityAntipsychotic use and hepatic safety in the first 30 days post-liver transplant
Karaj Singh - Rush UniversityImproving Recognition of Heterogeneous Catatonia: Laboratory Biomarkers, Communication Gaps, and Medication Reconciliation in Patients Receiving Long-Acting Injectable Antipsychotics
Mathew Thariath - Loyola Stritch School of MedicineExploring the Relationship Between Medication Adherence and Barriers in Adolescent Psychiatric Treatment Planning: A Prospective Study
Caitlin Trottier - Loyola Stritch School of MedicineAdverse Childhood Experiences and Leadership Traits in Executives: Associations with Altruism, Shame, and Hyper-Competitiveness
Jesus Junior Vallejo Cardenas - Rosalind FranklinPsychiatric Comorbidities in Psychogenic Nonepileptic Seizures (PNES) and Epilepsy: Analysis of an Inpatient Pediatric Unit and Consultation-Liaison Psychiatry Service
Vanessa Villalpando - Loyola University Chicago Stritch -
IPS Planning Committee:
A big THANK YOU goes out to the members of the IPS Planning Committee for all of their hard work in putting together this year’s Annual Meeting and all of the IPS events throughout the year!
If you would like to join the IPS Planning Committee, please contact Kristen Malloy at kmalloy@ilpsych.org.
Planning Committee Members:
Adrienne Adams, MD
Mercy Eigbike, MD
L. Joy Houston, MD—Chair
Andrew Lancia, MD
Kimberly Meyer, MD
Susan Scherer, MD
Jasleen Singh, MD
Steve Weinstein, MD
Thank you to our Annual Meeting Sponsors!
